These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7730955)

  • 1. Polymer-coated liposomes: improved liposome stability and release of cytosine arabinoside (Ara-C).
    Sehgal S; Rogers JA
    J Microencapsul; 1995; 12(1):37-47. PubMed ID: 7730955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of vinblastine into transfersomes and liposomes in response to a transmembrane ammonium sulfate gradient and their cytotoxic/cytostatic activity in vitro.
    Maswadeh H; Demetzos C; Dimas K; Hatziantoniou S; Georgopoulos A; Rallis M; Dallas P; Papaioannou G
    Anticancer Res; 2001; 21(4A):2577-83. PubMed ID: 11724324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(4-vinylpyridine)-coated liposomes: stability studies and release of acetylsalicylic acid.
    Dong C; Rogers JA
    J Microencapsul; 1992; 9(4):437-48. PubMed ID: 1403491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical stability of different liposome compositions obtained by extrusion method.
    Armengol X; Estelrich J
    J Microencapsul; 1995; 12(5):525-35. PubMed ID: 8544096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of ciprofloxacin liposomes: derivative ultraviolet spectrophotometric determinations.
    Gürsoy A; Senyücel B
    J Microencapsul; 1997; 14(6):769-76. PubMed ID: 9394258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.
    Justo OR; Moraes AM
    J Pharm Pharmacol; 2005 Jan; 57(1):23-30. PubMed ID: 15638989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.
    Jaafar-Maalej C; Diab R; Andrieu V; Elaissari A; Fessi H
    J Liposome Res; 2010 Sep; 20(3):228-43. PubMed ID: 19899957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit.
    Khattab MA; Farr SJ; Taylor G; Kellaway IW
    J Drug Target; 1995; 3(1):39-49. PubMed ID: 7655819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
    Alipour M; Halwani M; Omri A; Suntres ZE
    Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes.
    Xu Q; Tanaka Y; Czernuszka JT
    Biomaterials; 2007 Jun; 28(16):2687-94. PubMed ID: 17331574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
    Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
    Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization of multilamellar liposomes in the presence of non-ionized drug.
    Habib MJ; Akogyeram CO; Ngofa EN; Biswas M; Betageri GV
    Membr Biochem; 1993; 10(3):145-54. PubMed ID: 8231897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
    Carafa M; Marianecci C; Annibaldi V; Di Stefano A; Sozio P; Santucci E
    Int J Pharm; 2006 Nov; 325(1-2):155-62. PubMed ID: 16884870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM; Mehra T; Hansen C; Chin YC
    Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations.
    Anderson M; Omri A
    Drug Deliv; 2004; 11(1):33-9. PubMed ID: 15168789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as a potential drug carrier for citicoline (CDP-choline) and the effect of formulation conditions on encapsulation efficiency.
    Puglisi G; Fresta M; La Rosa C; Ventura CA; Panico AM; Mazzone G
    Pharmazie; 1992 Mar; 47(3):211-5. PubMed ID: 1615027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
    Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of liposomal gene therapy vectors by a scalable method without using volatile solvents or detergents.
    Mortazavi SM; Mohammadabadi MR; Khosravi-Darani K; Mozafari MR
    J Biotechnol; 2007 May; 129(4):604-13. PubMed ID: 17353061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome.
    Gillet A; Grammenos A; Compère P; Evrard B; Piel G
    Int J Pharm; 2009 Oct; 380(1-2):174-80. PubMed ID: 19576972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-palmitoylcurdlan sulfate (OPCurS)-coated liposomes for oral drug delivery.
    Lee CM; Lee HC; Lee KY
    J Biosci Bioeng; 2005 Sep; 100(3):255-9. PubMed ID: 16243273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.